Synthesis and biological evaluation of 1,3,4-triaryl-3-pyrrolin-2-ones, a new class of selective cyclooxygenase-2 inhibitors
- 18 July 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (15) , 1745-1748
- https://doi.org/10.1016/s0960-894x(00)00329-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Dynamics of Prostaglandin H SynthasesPublished by Elsevier ,1998
- The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory DrugsMolecular Pharmacology, 1997
- Conversion of Prostaglandin G/H Synthase-1 into an Enzyme Sensitive to PGHS-2-selective Inhibitors by a Double His513→ Arg and Ile523→ Val MutationPublished by Elsevier ,1997
- Risk of Alzheimer's disease and duration of NSAID useNeurology, 1997
- Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2Cell, 1996
- Diarylspiro[2.4]heptenes as Orally Active, Highly Selective Cyclooxygenase-2 Inhibitors: Synthesis and Structure−Activity RelationshipsJournal of Medicinal Chemistry, 1996
- NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitroProstaglandins, 1994
- Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1992
- A computational procedure for determining energetically favorable binding sites on biologically important macromoleculesJournal of Medicinal Chemistry, 1985
- A new force field for molecular mechanical simulation of nucleic acids and proteinsJournal of the American Chemical Society, 1984